Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target

Arch Virol. 2023 Jul 31;168(8):213. doi: 10.1007/s00705-023-05842-2.

Abstract

T cell immunoglobulin and mucin domain containing protein 3 (Tim-3), an immune checkpoint, is important for maintaining immune tolerance. There is increasing evidence that Tim-3 is aberrantly expressed in patients with COVID-19, indicating that it may play an important role in COVID-19. In this review, we discuss the altered expression and potential role of Tim-3 in COVID-19. The expression of Tim-3 and its soluble form (sTim-3) has been found to be upregulated in COVID-19 patients. The levels of Tim-3 on T cells and circulating sTim-3 have been shown to be associated with the severity of COVID-19, suggesting that this protein could be a potential biomarker of COVID-19. Moreover, this review also highlights the potential of Tim-3 as a therapeutic target of COVID-19.

Keywords: COVID-19; Immune response; Tim-3.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • COVID-19*
  • Hepatitis A Virus Cellular Receptor 2* / genetics
  • Hepatitis A Virus Cellular Receptor 2* / metabolism
  • Humans
  • T-Lymphocytes / metabolism

Substances

  • Hepatitis A Virus Cellular Receptor 2
  • Biomarkers